Biotech index rises above $100 mark for first time in two years
After a roller coaster of a two-year ride, the biotech market’s key stock index, the $XBI, surpassed the $100 mark on Tuesday, buoying investor optimism …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
